(MENAFN- GetNews)
“Trends and Forecast for the Global Interventional Cardiology and Peripheral Vascular Device Market” Trends, opportunities and forecast in interventional cardiology and peripheral vascular device market to 2025 by type (interventional cardiology device and peripheral vascular device), device (angioplasty balloons, angioplasty stents, angioplasty catheters, EVAR stent grafts, IVC filters, embolic protection devices, guidewires, arteriotomy closure devices, intravascular ultrasound systems (IVUS), and synthetic surgical grafts), end use (hospitals and ambulatory surgical centers) and region
Lucintel's latest market report analyzed that interventional cardiology and peripheral vascular device provides attractive opportunities in hospitals and ambulatory surgical centers. The interventional cardiology and peripheral vascular device market is expected to reach $29.9billion by 2025 with a CAGR of 4.7%. In this market, EVAR stent graft is the largest segment by device type, whereas a hospital is largest by end use industry. The rising adoption of TAVR procedures, increasing use of bioresorbable stents, and a rise in adoption of drug eluting balloons provides strategic growth path in this market.
Download Brochure of this report by clicking on
Based on device type, the interventional cardiology and peripheral vascular device market is segmented into angioplasty balloons, angioplasty stents, angioplasty catheters, EVAR stent grafts, IVC filters, embolic protection devices, guidewires, arteriotomy closure devices, intravascular ultrasound systems (IVUS), and synthetic surgical grafts. The EVAR stent grafts segment is accounted for the largest share of the market in 2020 and is expected to register the highest CAGR during the forecast period.
Browse in-depth TOC on“Interventional Cardiology and Peripheral Vascular device Market”
66 – Tables
115 – Figures
196 – Pages
The interventional cardiology and peripheral vascular device market is marked by the presence of several big and small players. Some of the prominent players offering Interventional cardiology and peripheral vascular device include Medtronic Plc, Boston Scientific, Abbott Laboratories, Terumo, and C R Bard and others.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link .
About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting , M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit .
MENAFN23112021003238003268ID1103238475
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.